(Q35669835)

9 August 2017

1 reference

title

SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations (English)

1 reference

post-traumatic stress disorder

9 August 2017

0 references

author name string

Gregory M Asnis

1

1 reference

9 August 2017

Shari R Kohn

2

1 reference

9 August 2017

Margaret Henderson

3

1 reference

9 August 2017

Nicole L Brown

4

1 reference

9 August 2017

language of work or name

1 reference

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

64

1 reference

9 August 2017

383-404

1 reference

9 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464040-00004

9 August 2017

0 references

cites work

Gabapentin in the Treatment of Posttraumatic Stress Disorder

1 reference

12 December 2020

New directions in the pharmacotherapy of posttraumatic stress disorder

1 reference

12 December 2020

Comorbidity, Impairment, and Suicidality in Subthreshold PTSD

1 reference

12 December 2020

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

12 December 2020

Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder

1 reference

12 December 2020

An open trial of fluoxetine in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Antidepressant drug selection: criteria and options.

1 reference

12 December 2020

Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder

1 reference

12 December 2020

Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder

1 reference

12 December 2020

Outcomes of posttraumatic stress disorder.

1 reference

12 December 2020

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

12 December 2020

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

12 December 2020

Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence.

1 reference

12 December 2020

Efficacy of Buspirone in the Treatment of Posttraumatic Stress Disorder: An Open Trial

1 reference

12 December 2020

Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey

1 reference

12 December 2020

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

1 reference

12 December 2020

Open prospective trial of fluoxetine for posttraumatic stress disorder.

1 reference

12 December 2020

Association between the dopamine transporter gene and posttraumatic stress disorder

1 reference

12 December 2020

Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

12 December 2020

Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment

1 reference

12 December 2020

Comorbidity of psychiatric disorders and posttraumatic stress disorder.

1 reference

12 December 2020

Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy

1 reference

12 December 2020

Monoamine oxidase inhibitors. An update on drug interactions

1 reference

12 December 2020

Clozapine treatment for a veteran with comorbid psychosis and PTSD.

1 reference

12 December 2020

The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: a report of 4 cases.

1 reference

12 December 2020

Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.

1 reference

12 December 2020

A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder

1 reference

12 December 2020

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

1 reference

12 December 2020

Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder

1 reference

12 December 2020

Continuation and maintenance therapy in depression

1 reference

12 December 2020

Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease

1 reference

12 December 2020

Nefazodone in patients with treatment-refractory posttraumatic stress disorder

1 reference

12 December 2020

Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety

1 reference

12 December 2020

A pilot study of mirtazapine in post-traumatic stress disorder

1 reference

12 December 2020

Clonidine for posttraumatic stress disorder in preschool children

1 reference

12 December 2020

Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders

1 reference

12 December 2020

Chemotherapy of traumatic war stress

1 reference

12 December 2020

Monoamine oxidase inhibitors in posttraumatic stress disorder. Promise and problems in Indochinese survivors of trauma.

1 reference

12 December 2020

Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design

1 reference

12 December 2020

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

1 reference

12 December 2020

Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.

1 reference

12 December 2020

Gabapentin as a potential treatment for anxiety disorders.

1 reference

12 December 2020

Citalopram: a comprehensive review

1 reference

12 December 2020

Posttraumatic stress disorder in primary care

1 reference

12 December 2020

The pharmacologic profile of mirtazapine

1 reference

12 December 2020

Hypnotic medication in the aftermath of trauma

1 reference

12 December 2020

Fluvoxamine in civilians with posttraumatic stress disorder

1 reference

12 December 2020

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

12 December 2020

Tricyclics: possible treatment for posttraumatic stress disorder.

1 reference

12 December 2020

Neuroreceptor mechanisms of aggression and its treatment.

1 reference

12 December 2020

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

1 reference

12 December 2020

The expert consensus guideline series. Treatment of Posttraumatic Stress Disorder. The Expert Consensus Panels for PTSD

1 reference

12 December 2020

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

1 reference

12 December 2020

Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms

1 reference

12 December 2020

Treatment of traumatic war neurosis with phenelzine

1 reference

12 December 2020

Suicidal behaviors in adult psychiatric outpatients, I: Description and prevalence

1 reference

12 December 2020

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Withdrawal syndrome in a depressed patient treated with trazodone

1 reference

12 December 2020

A controlled trial of phenelzine in posttraumatic stress disorder.

1 reference

12 December 2020

The anti-anxiety and anti-agitation effects of paroxetine in depressed patients

1 reference

12 December 2020

An open trial of moclobemide in the treatment of post-traumatic stress disorder

1 reference

12 December 2020

Gabapentin treatment for posttraumatic stress disorder

1 reference

12 December 2020

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

1 reference

12 December 2020

Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment

1 reference

12 December 2020

Open trial of nefazodone for combat-related posttraumatic stress disorder

1 reference

12 December 2020

Fluvoxamine treatment for chronic PTSD: a pilot study

1 reference

12 December 2020

Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder.

1 reference

12 December 2020

Noradrenergic and serotonergic function in posttraumatic stress disorder

1 reference

12 December 2020

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

1 reference

12 December 2020

Preliminary study of carbamazepine in post-traumatic stress disorder

1 reference

12 December 2020

Nonpsychiatric Illness Among Primary Care Patients With Trauma Histories and Posttraumatic Stress Disorder

1 reference

12 December 2020

Olanzapine treatment for post-traumatic stress disorder: an open-label study

1 reference

12 December 2020

Management of posttraumatic stress disorder: diagnostic and therapeutic issues.

1 reference

12 December 2020

Trazodone for antidepressant-associated insomnia.

1 reference

12 December 2020

Sertraline in the treatment of rape victims with posttraumatic stress disorder.

1 reference

12 December 2020

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

12 December 2020

Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers.

1 reference

12 December 2020

Treatment of post-traumatic stress disorder with imipramine

1 reference

12 December 2020

Fluoxetine and fluvoxamine in PTSD

1 reference

12 December 2020

Fear, anger and compulsive behavior during seizure: involvement of large scale fronto-temporal neural networks.

1 reference

12 December 2020

Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study.

1 reference

12 December 2020

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Quality of life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo-controlled trial of fluoxetine.

1 reference

12 December 2020

Buspirone in combat-related posttraumatic stress disorder

1 reference

12 December 2020

Posttraumatic stress disorder: the burden to the individual and to society

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

1 reference

12 December 2020

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

1 reference

12 December 2020

Biological markers of affective disorders and posttraumatic stress disorder: a pilot study with desipramine.

1 reference

12 December 2020

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment

1 reference

12 December 2020

Trauma: prevalence, impairment, service use, and cost.

1 reference

12 December 2020

Use of thioridazine in post-traumatic stress disorder

1 reference

12 December 2020

Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD.

1 reference

12 December 2020

Treatment of depression in patients with heart disease.

1 reference

12 December 2020

The safety profile of nefazodone

1 reference

12 December 2020

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

1 reference

12 December 2020

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

1 reference

12 December 2020

Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder

1 reference

12 December 2020

The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings

1 reference

12 December 2020

Fluoxetine in posttraumatic stress disorder

1 reference

12 December 2020

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

12 December 2020

Nefazodone in post-traumatic stress disorder: results from six open-label trials

1 reference

12 December 2020

Serotonergic agents in the management of dementia and posttraumatic stress disorder

1 reference

12 December 2020

Bupropion treatment in veterans with posttraumatic stress disorder: an open study

1 reference

12 December 2020

Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans

1 reference

12 December 2020

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

12 December 2020

Cognitive side effects of anticonvulsants.

1 reference

12 December 2020

Posttraumatic stress disorder in the National Comorbidity Survey

1 reference

12 December 2020

Valproate in combat-related posttraumatic stress disorder.

1 reference

12 December 2020

Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.

1 reference

12 December 2020

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

1 reference

12 December 2020

Treatment of recent trauma survivors with benzodiazepines: a prospective study.

1 reference

12 December 2020

Antidepressants and antipsychotics in the long-term treatment of bipolar disorder

1 reference

12 December 2020

Functional impairment and utilization of services associated with posttraumatic stress in the community.

1 reference

12 December 2020

1 reference

12 December 2020

Alprazolam in the treatment of posttraumatic stress disorder

1 reference

12 December 2020

Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment

1 reference

12 December 2020

A Pilot Study of Phenelzine in the Treatment of Post-traumatic Stress Disorder

1 reference

12 December 2020

Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.

1 reference

12 December 2020

Monoamine Oxidase Inhibitors

1 reference

12 December 2020

10.2165/00003495-200464040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

0 references

1 reference